38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely pirfenidone 801 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pirfenidone 267 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pirfenidone 267 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely stiripentol 500 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely stiripentol 500 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only pirfenidone in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely stiripentol 250 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely stiripentol 250 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Lenalidomide 20 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Lenalidomide 20 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Lenalidomide 2.5 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Lenalidomide 2.5 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely lenalidomide 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lenalidomide 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Lenalidomide 15 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Lenalidomide 15 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely erdosteine 300 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely erdosteine 300 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only erdosteine in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lenvatinib (as lenvatinib mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lenvatinib (as lenvatinib mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely lenvatinib (as lenvatinib mesilate) 4 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lenvatinib (as lenvatinib mesilate) 4 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only bromhexine (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Bromhexine only product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing only meloxicam in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only Neisseria meningitidis serogroup B antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Neisseria meningitidis antigen only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only amisulpride in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only live attenuated Yellow fever virus antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Rimegepant only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only rimegepant in oral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in brain tissue (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only live attenuated Rotavirus antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only isatuximab (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Isatuximab only product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Bacillus anthracis antigen only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only Human papillomavirus 16 and 18 antigens (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Human papillomavirus 6, 11, 16 and 18 antigens only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only live attenuated Junin virus antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vibrio cholerae antigen only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Influenza virus antigen only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only Human papillomavirus antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Streptococcus pneumoniae antigen only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Vibrio cholerae antigen only vaccine product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Lasmiditan 50 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Lasmiditan 50 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only inactivated whole Hepatitis A virus antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide unconjugated antigen only vaccine product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only Clostridium tetani toxoid antigen (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Live attenuated Human poliovirus serotypes 1 and 3 antigens only vaccine product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Bacillus Calmette-Guerin antigen only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Haemophilus influenzae type b capsular polysaccharide antigen conjugated only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Bacillus Calmette-Guerin antigen only vaccine product in parenteral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only osilodrostat (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Osilodrostat only product in oral dose form	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely osilodrostat (as osilodrostat phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely osilodrostat (as osilodrostat phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Osilodrostat (as osilodrostat phosphate) 10 mg oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Osilodrostat (as osilodrostat phosphate) 10 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria lineage antigens only vaccine product	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only Streptococcus pneumoniae capsular polysaccharide antigen conjugated (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product)	Count of base of active ingredient	False	1	Inferred relationship	Some
Ibrutinib 140 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Ibrutinib 140 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely nitisinone 20 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely nitisinone 20 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Minoxidil 50 mg/mL cutaneous solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Minoxidil 50 mg/mL cutaneous solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely midostaurin 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely midostaurin 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Palbociclib 75 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Palbociclib 75 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely palbociclib 125 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely palbociclib 125 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely panobinostat (as panobinostat lactate) 15 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely panobinostat (as panobinostat lactate) 15 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Panobinostat (as panobinostat lactate) 10 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Panobinostat (as panobinostat lactate) 10 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Eliglustat (as eliglustat tartrate) 84 mg oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Eliglustat (as eliglustat tartrate) 84 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1

Start Previous Page 208 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core